Submit Manuscript  

Article Details

Discovery of Novel Lead in the Group of N-substituted Piperazine Ether Derivatives with Potential Histamine H3 Receptor Activity

[ Vol. 10 , Issue. 6 ]


Kamil J. Kuder, Marta Stachnik, Walter Schunack, Ewa Szyman ska and Katarzyna Kiec -Kononowicz   Pages 588 - 599 ( 12 )


The search for novel lead from the group of various substituted N-piperazine ether derivatives was performed. Acyl- and pyridylpiperazine ethyl/propyl ethers were obtained via three different synthetic pathways. Affinity to histamine H3 receptor was established, as well as, for selected compounds, selectivity towards histamine H4R. Docking studies to the histamine H3R homology model strengthened the position of (4-(3-(4-(3-chlorobenzoyl)piperazin-1- yl)propoxy)phenyl)(cyclopropyl)methanone (compound 26) as a novel lead for further studies on histamine H3 receptor antagonist/inverse agonist.


Acylpiperazine, histamine H3R affinity, histamine H4R affinity, molecular docking, non-imidazole histamine H3R ligands.


Department of Technology and Biotechnology of Drugs, Jagiellonian University, Medical College, Krakow, 30-688, Poland.

Graphical Abstract:

Read Full-Text article